resident – Page 3 – Communicable Diseases Research

Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents

Observational Study

Published on 2022-07-012022-10-04
Journal: Drugs & aging [Category] Coronavirus, COVID19(2023년), SARS, 임상,

Anthropomorphic Character Animations Versus Digital Chalk Talks in a Resident Diabetes Pharmacotherapy Curriculum: a Randomized Controlled Trial

Randomized Controlled Trial

Published on 2022-07-012022-10-05
Journal: Journal of General Internal Medicine [Category] 임상,

Immune Responses Against SARS-CoV-2 WT and Delta Variant in Elderly BNT162b2 Vaccinees

노인 BNT162b2 백신의 SARS-CoV-2 WT 및 Delta 변이체에 대한 면역 반응

Article

Published on 2022-06-272022-09-11
Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술,

[키워드] Against age Age-dependent immune responses after BNT162b2 analyzed antibody Antibody titer Antibody titers B.1.617.2 Blood BNT162b2 booster cellular cohorts coronavirus COVID-19 Delta delta variant elderly ELISPOT group groups highlighting humoral immune response IFNγ IgG titers immune response immune responses Immunoglobulin Immunoglobulin G mononuclear cell mononuclear cells neutralization ability neutralization activities neutralization activity neutralization titer neutralization titers Neutralizing Neutralizing activity Neutralizing antibodies nursing homes overcome pandemic participant peripheral Peripheral blood Peripheral blood mononuclear cells resident response rising SARS-CoV-2 SARS-CoV-2 delta SARS-CoV-2 spike protein SARS-CoV-2 vaccination SARS-CoV-2 WT second vaccination significantly increased specific antibodies Spike protein syndrome T cell T cell immunity T cell response vaccination vaccine dose vaccinee vaccinees Vaccines variants variants of concern variants of concern (VOCs) variants of SARS-CoV-2 Virus neutralization VOCs wild-type
[DOI] 10.3389/fimmu.2022.868361 PMC 바로가기 [Article Type] Article

COVID-19 Preventive Measures in Northern California Jails: Perceived Deficiencies, Barriers, and Unintended Harms

북부 캘리포니아 감옥의 COVID-19 예방 조치: 인식된 결함, 장벽 및 의도하지 않은 피해

Article

Published on 2022-06-142022-09-12
Journal: Frontiers in Public Health [Category] COVID19(2023년), MERS, SARS, 진단,

[키워드] 95% CI adjusted Administered antibody Antibody testing Characteristics community-based research condition COVID-19 COVID-19 diagnosis COVID-19 transmission Deprivation effort enrolled exacerbate Face masks Factor hidden Impact implementation incarcerated incarceration individuals Infection infection control Interpretation Isolation jails likelihood lockdown Masks measure Mental mental health mitigate multivariable logistic regression pandemic Perceived performed positive questionnaire reported Research resident response SARS-CoV-2 Seroprevalence significantly stakeholder engagement Study design Symptom tested vaccination
[DOI] 10.3389/fpubh.2022.854343 PMC 바로가기 [Article Type] Article

Clinical evaluation of single-swab sampling for rapid COVID-19 detection in outbreak settings in Dutch nursing homes

네덜란드 요양원의 발병 환경에서 신속한 COVID-19 감지를 위한 단일 면봉 샘플링의 임상 평가

Article

Published on 2022-06-012022-09-11
Journal: European Geriatric Medicine [Category] COVID19(2023년), SARS, 치료기술,

[키워드] addition Ag-RDT Antigen antigen-detection can be used Care Chain Reaction Characteristics clinical collected comparable coronavirus COVID-19 Ct value Cycle threshold values diagnostic test dilemma disadvantage Disadvantages effective equipment evaluated feasibility feasible group groups implementation involved Laboratory Long-term care Long-term care facility medium not differ nursing home occurred Older adults outbreak performed polymerase chain polymerase chain reaction professional Rapid diagnostic test resident reverse transcriptase Reverse transcriptase polymerase chain reaction RT-PCR SARS-CoV-2 sensitivity specificity stratified Swab Symptomatology Testing transcriptase Transport transport medium
[DOI] 10.1007/s41999-021-00584-3 PMC 바로가기 [Article Type] Article

Changing Dynamics of COVID-19 Deaths During the SARS-CoV2 B.1.617.2 (Delta Variant) Outbreak in England and Wales: Reduced COVID-19 Deaths Among the Care Home Residents

SARS-CoV2 B.1.617.2(델타 변종) 발병 중 COVID-19 사망의 역학 변화 잉글랜드 및 웨일즈: 요양원 거주자 중 COVID-19 사망 감소

Article

Published on 2022-06-012022-09-11
Journal: Journal of the American Medical Directors Associat [Category] COVID19(2023년), SARS, 변종,

[키워드] B.1.617.2 Changing COVID-19 Delta Dynamics England home resident SARS-CoV2
[DOI] 10.1016/j.jamda.2022.04.002 PMC 바로가기 [Article Type] Article

Adverse events following third dose of mRNA COVID-19 vaccination among nursing home residents who received the primary series

1차 시리즈를 받은 요양원 거주자 중 mRNA COVID-19 백신 3차 접종 후 부작용

Article

Published on 2022-06-012022-09-11
Journal: Journal of the American Geriatrics Society [Category] COVID19(2023년), SARS, 치료기술,

[키워드] 95% CI adjust Administered administration Adverse adverse event adverse events adverse events after vaccination booster booster COVID-19 vaccination booster dose CDC COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines dose Electronic health record Electronic health records event event rate event rates false discovery rate genesis Ischemic Stroke medical condition Medical conditions mRNA mRNA vaccine multiple comparisons multiplicity no significant differences nursing home nursing homes occurred prospective cohort reported resident Safety screened significant difference significant differences statistically significant tested vaccination rate venous Venous Thromboembolism
[DOI] 10.1111/jgs.17812 PMC 바로가기 [Article Type] Article

Immune Response 5-7 Months after Vaccination against SARS-CoV-2 in Elderly Nursing Home Residents in the Czech Republic: Comparison of Three Vaccines

체코의 노인 요양원 거주자의 SARS-CoV-2 예방 접종 후 5-7개월의 면역 반응: 3가지 백신의 비교

Article

Published on 2022-05-182022-09-11
Journal: Viruses [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료법,

[키워드] 95% CI 95% confidence interval anti-S IgG antibody appear approach AstraZeneca booster dose cellular cellular immunity completion complex convalescent correlated Course COVID-19 elderly elderly nursing home residents evaluated expected home Humoral immunity IgG antibodies IgG antibody immune parameter immune response Immunity individual interferon matter Moderna Month neutralization capacity nucleocapsid protein Nursing nursing home occurred omicron participant patients Pfizer positive positive result Prevalence resident response Result sampling SARS-CoV-2 SARS-COV-2 infection significantly higher Spike protein subset tested titer took place vaccination Vaccine Vaccines Virus neutralization was reduced
[DOI] 10.3390/v14051086 PMC 바로가기 [Article Type] Article

Vaccine Side Effects Following COVID-19 Vaccination Among the Residents of the UAE-An Observational Study

Observational Study

Published on 2022-05-062022-10-04
Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 임상,

[키워드] 95% CI adverse (side) effects. adverse effect adverse event age analyzed average clinical trials comorbid conditions Comorbidities conducted COVID-19 COVID-19 infection COVID-19 vaccination COVID-19 vaccine difference Effect Effects Evidence Factor fatigue female gender Gender headache higher odd inactivated inactive individual injection less Mild mRNA mRNA vaccine Odds ratio Pain Pfizer Pfizer-BioNTech Pfizer-BioNTech vaccine recipient recipients reported resident Safe SARS-CoV-2 severity side Side effect Sinopharm Sinopharm vaccine statistically significant survey platform Treatment Vaccine
[DOI] 10.3389/fpubh.2022.876336 PMC 바로가기 [Article Type] Observational Study

Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant – United States, February 14-March 27, 2022

2022년 2월 14일-3월 27일, 미국, 2022년 2월 14일-3월 27일, 미국, 2022년 2월 14일-3월 27일

Article

Published on 2022-05-062022-09-11
Journal: Morbidity and Mortality Weekly Report [Category] COVID19(2023년), SARS, 변종,

[키워드] 95% CI accounted Ad26 analyzed B.1.1.529 BNT162b2 booster dose booster doses Booster vaccine cause CDC conjunction Coverage COVID-19 COVID-19 vaccination COVID-19 vaccine Decline defined dose Effectiveness eligible greater home Immunocompromised include Infection infection with SARS-CoV-2 isolates Johnson & Johnson morbidity and mortality mRNA mRNA vaccine mRNA-1273 network NHSN Nursing nursing home omicron Omicron variant Pfizer-BioNTech Preventing primary dose PROTECT receipt receive reported resident Safety SARS-CoV-2 sequenced Surveillance United States vaccination Vaccine Vaccine-induced immunity Variability variant variants virus Weekly
[DOI] 10.15585/mmwr.mm7118a4 PMC 바로가기 [Article Type] Article